Graviton Bioscience Corporation

Allorion

This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.

BlossomHill Therapeutics

This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.

Matchpoint Therapeutics

This biotechnology company develops oral covalent small molecule medicines to treat patients with autoimmune and inflammatory diseases.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

Galecto

This biotechnology company develops small molecule therapeutics targeting galectin-3 and LOXL2 to treat patients with fibrosis, inflammation and cancer.

Alevin Therapeutics

This biotechnology company develops small molecule integrin inhibitors to treat patients with life-threatening fibrotic diseases, including lung, liver and kidney conditions.

SFA Theraputics

This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.